Safety and efficacy, adaptive control algorithm to be tested in U.S. and Europe.

β-cell centric classification of diabetes puts focus on single common denominator of all types.

New pen may improve glycemic control in people with severely insulin-resistant diabetes.

Current black box warning may be overstating the kidney risk.

New nutrition recommendations filled with numerous changes.

Surgery could lower patients' development of future medical issues.

In part one of this special interview, Dr. Stanley Schwartz and DIC publisher Steve Freed discuss Dr. Schwartz's proposed new beta-cell centric classification of diabetes.

In part two of this special interview, Dr. Schwartz discusses the "egregious eleven" -- six mechanisms that injure the beta cell, and five results of injury -- and the role they play in hyperglycemia.

In part three of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses how the new beta-cell classification supports a patient-centric, "precision medicine" approach to diabetes care, and enables more targeted treatments for hyperglycemia.

In part four of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses the need for better markers in improving individualization of diabetes patient care.